KMT2D and head and neck squamous cell carcinoma: Further scrutinizing the epigenomic changes in HNSCC following glycolysis inhibition, we unexpectedly discover that KMT2D deficiency reprograms the epigenetic landscapes of HNSCC and impairs the expression of FA/BRCA pathway genes under glucose deprivation.